Gourdon G - Search Results

1

Electrophysiological basis of cardiac arrhythmia in a mouse model of myotonic dystrophy type 1.

Ginjupalli VKM, Cupelli M, Reisqs JB, Sleiman Y, El-Sherif N, Gourdon G, Puymirat J, Chahine M, Boutjdir M. Ginjupalli VKM, et al. Among authors: gourdon g. Front Physiol. 2023 Sep 21;14:1257682. doi: 10.3389/fphys.2023.1257682. eCollection 2023. Front Physiol. 2023. PMID: 37811496 Free PMC article.

2

Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1.

Ait Benichou S, Jauvin D, De Serres-Bérard T, Pierre M, Ling KK, Bennett CF, Rigo F, Gourdon G, Chahine M, Puymirat J. Ait Benichou S, et al. Among authors: gourdon g. Gene Ther. 2022 Dec;29(12):698-709. doi: 10.1038/s41434-022-00316-7. Epub 2022 Jan 25. Gene Ther. 2022. PMID: 35075265 Free PMC article.

3

Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting Dystrophia Myotonica Protein Kinase Transcripts for the Treatment of Myotonic Dystrophy Type 1.

Ait Benichou S, Jauvin D, De Serres-Bérard T, Bennett F, Rigo F, Gourdon G, Boutjdir M, Chahine M, Puymirat J. Ait Benichou S, et al. Among authors: gourdon g. Hum Gene Ther. 2022 Aug;33(15-16):810-820. doi: 10.1089/hum.2022.069. Hum Gene Ther. 2022. PMID: 35794764

4

Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice.

Jauvin D, Chrétien J, Pandey SK, Martineau L, Revillod L, Bassez G, Lachon A, MacLeod AR, Gourdon G, Wheeler TM, Thornton CA, Bennett CF, Puymirat J. Jauvin D, et al. Among authors: gourdon g. Mol Ther Nucleic Acids. 2017 Jun 16;7:465-474. doi: 10.1016/j.omtn.2017.05.007. Epub 2017 May 17. Mol Ther Nucleic Acids. 2017. PMID: 28624222 Free PMC article.

5

Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice.

Klein AF, Varela MA, Arandel L, Holland A, Naouar N, Arzumanov A, Seoane D, Revillod L, Bassez G, Ferry A, Jauvin D, Gourdon G, Puymirat J, Gait MJ, Furling D, Wood MJ. Klein AF, et al. Among authors: gourdon g. J Clin Invest. 2019 Nov 1;129(11):4739-4744. doi: 10.1172/JCI128205. J Clin Invest. 2019. PMID: 31479430 Free PMC article.

6

RBFOX1 cooperates with MBNL1 to control splicing in muscle, including events altered in myotonic dystrophy type 1.

Klinck R, Fourrier A, Thibault P, Toutant J, Durand M, Lapointe E, Caillet-Boudin ML, Sergeant N, Gourdon G, Meola G, Furling D, Puymirat J, Chabot B. Klinck R, et al. Among authors: gourdon g. PLoS One. 2014 Sep 11;9(9):e107324. doi: 10.1371/journal.pone.0107324. eCollection 2014. PLoS One. 2014. PMID: 25211016 Free PMC article.

7

Excessive rest time during active phase is reliably detected in a mouse model of myotonic dystrophy type 1 using home cage monitoring.

Golini E, Rigamonti M, Raspa M, Scavizzi F, Falcone G, Gourdon G, Mandillo S. Golini E, et al. Among authors: gourdon g. Front Behav Neurosci. 2023 Mar 2;17:1130055. doi: 10.3389/fnbeh.2023.1130055. eCollection 2023. Front Behav Neurosci. 2023. PMID: 36935893 Free PMC article.

8

Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus.

Huguet A, Medja F, Nicole A, Vignaud A, Guiraud-Dogan C, Ferry A, Decostre V, Hogrel JY, Metzger F, Hoeflich A, Baraibar M, Gomes-Pereira M, Puymirat J, Bassez G, Furling D, Munnich A, Gourdon G. Huguet A, et al. Among authors: gourdon g. PLoS Genet. 2012;8(11):e1003043. doi: 10.1371/journal.pgen.1003043. Epub 2012 Nov 29. PLoS Genet. 2012. PMID: 23209425 Free PMC article.

9

Progressive skeletal muscle weakness in transgenic mice expressing CTG expansions is associated with the activation of the ubiquitin-proteasome pathway.

Vignaud A, Ferry A, Huguet A, Baraibar M, Trollet C, Hyzewicz J, Butler-Browne G, Puymirat J, Gourdon G, Furling D. Vignaud A, et al. Among authors: gourdon g. Neuromuscul Disord. 2010 May;20(5):319-25. doi: 10.1016/j.nmd.2010.03.006. Epub 2010 Mar 25. Neuromuscul Disord. 2010. PMID: 20346670

10

Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy.

Lutz M, Levanti M, Karns R, Gourdon G, Lindquist D, Timchenko NA, Timchenko L. Lutz M, et al. Among authors: gourdon g. Int J Mol Sci. 2023 Jun 26;24(13):10650. doi: 10.3390/ijms241310650. Int J Mol Sci. 2023. PMID: 37445828 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page